Navigation Links
Steroids aid recovery from pneumonia, UT Southwestern researchers say
Date:10/14/2008

DALLAS Oct. 14, 2008 Adding corticosteroids to traditional antimicrobial therapy might help people with pneumonia recover more quickly than with antibiotics alone, UT Southwestern Medical Center scientists have found.

Unlike the anabolic steroids used to bulk up muscle, corticosteroids are often used to treat inflammation related to infectious diseases, such as bacterial meningitis. Used against other infectious diseases, however, steroid therapy has been shown to be ineffective or even harmful.

In a study available online and in a future issue of the Journal of Infectious Diseases, researchers at UT Southwestern show that mice infected with a type of severe bacterial pneumonia and subsequently treated with steroids and antibiotics recovered faster and had far less inflammation in their lungs than mice treated with antibiotics alone.

"Some people might think that if you give steroids, it would counteract the effect of the antibiotic," said Dr. Robert Hardy, associate professor of internal medicine and pediatrics and the study's senior author. "But it turns out you need the antibiotic to kill the bug and the steroid to make the inflammation in the lung from the infection get better. The steroids don't kill the bugs, but they do help restore health."

Pneumonia is a lung infection typically characterized by breathing difficulties and spread by coughing and sneezing. Symptoms include headache, fever, chills, coughs, chest pain, sore throat and nausea. Pneumonia caused by the Mycoplasma pneumoniae bacterium is generally a less severe form of the disease that can occur in any age group. It accounts for 20 percent to 30 percent of all community-acquired pneumonia cases.

In the current study, mice infected with the M pneumoniae bacterium were treated daily with a placebo, an antibiotic, a steroid, or a combination of the antibiotic and steroid in order to investigate the effect on M pneumoniae-induce
'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

1

GOOD

Page: 1 2

Related medicine news :

1. Changes in sex steroids associated with menopause
2. Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids
3. Corticosteroids of Little Use Against Childhood Meningitis
4. ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more
5. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
6. Steroids Are Abused for Skin, Not Just Muscles
7. International Law Enforcement Operation Targets Underground Manufacture of Anabolic Steroids
8. Repeat steroids to premature infants linked to cerebral palsy
9. Batters may achieve dramatic increases in home runs through steroids
10. Steroids Seem Safe for Babies at Risk of Early Birth
11. Viant Statement on the CMS Recovery Audit Contractor Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Steroids aid recovery from pneumonia, UT Southwestern researchers say
Steroids aid recovery from pneumonia, UT Southwestern researchers say
(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...
(Date:5/23/2012)... Prior treatment with inhaled corticosteroids in patients with ... is associated with a lower incidence and severity ... from researchers in Spain. , A parapneumonic effusion ... that accumulates between the two pleural layers, the ... as a result of a pneumonia, lung abscess, ...
(Date:5/23/2012)... Researchers in the United Kingdom have determined ... anti-inflammatory properties, can be an effective treatment option ... a life-threatening complication that occurs in the majority ... is the leading cause of mortality after the ... when the body repeatedly rejects the transplanted lung ...
(Date:5/22/2012)... Magnetic resonance imaging (MRI) provides an indication ... significantly earlier than possible through clinical examination, according ... journal Radiology . , Women with ... Research has shown that women who receive this ... to achieve breast conservation than those receiving chemotherapy ...
(Date:5/22/2012)... Large randomized controlled trials (RCTs) are critical for ... Yet Canada provides scant support for these studies ... in CMAJ ( Canadian Medical Association ... and Hamilton Health Sciences, Hamilton, Ontario, with Dr. ... the analysis and appendix that Canada should provide ...
Breaking Medicine News(10 mins):Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Canada should significantly increase its funding of randomized clinical trials 2
... company WorldMed Assist says economic downturn has created an uptick in his ... benefit plans that have been dramatically scaled back. , ... Concord, CA ... there were many predictions how this would play out for the young ...
... Dr. Jane L. Delgado, President and CEO ... leading Hispanic health advocacy group, released the following statement ... and Tobacco Control Act, which will provide the Food ... products. "Fifteen years ago Congressman Waxman summoned the ...
... President Obama,s economic stimulus package encourages the use ... this area of healthcare reform to become a reality, ... providers.See video from Siemens (NYSE: SI ) ... Information technology (IT), or the sharing of ...
... fruit, combined with contraceptive pill and a genetic mutation, ... April 2 (HealthDay News) -- A rare set of ... genetic mutation almost cost a 42-year-old woman her leg, ... in the car one afternoon," said Dr. Lucinda Grande, ...
... sports athletesGOLDEN VALLEY, Minn., April 2 ... a history of developing talented, nationally and internationally recognized ... rugby. On Thursday, April 9, at 6 p.m., three ... intent in the Gym at Courage Center Golden Valley. ...
... around us, images flicker into our brains ,like so many ... our eyes move, which is several times a second. Yet ... display. , Why not? , Neuroscientists at The Johns Hopkins ... special region of the brain,s visual cortex ,which is in ...
Other Medicine News:Health News:Economic Turmoil Creates Boom for Medical Tourism 2Health News:Economic Turmoil Creates Boom for Medical Tourism 3Health News:Economic Turmoil Creates Boom for Medical Tourism 4Health News:National Alliance for Hispanic Health Statement on Passage of Bill Granting FDA Authority to Regulate Tobacco 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 3Health News:Courage Center Hosts College Scholarship Signing Ceremony Thursday, April 9, 2009 2Health News:JHU researcher discovers brain cells have 'memory' 2Health News:JHU researcher discovers brain cells have 'memory' 3
(Date:5/23/2012)... Tactile, Inc. (MTI), with the support of The Pre-Mammogram ... developed a pre-commercial SureTouch™ Wireless system that ... According to a publication funded by ... were diagnosed with breast cancer in 2010 and 425,000 ... the best means to a good prognosis for breast ...
(Date:5/23/2012)... 2012   CryoLife, Inc. (NYSE: ... cardiac and vascular surgery, announced today that it will ... One-on-One Investor Conference on Thursday, May 31, 2012 in ... chief operating officer, and chief financial officer of CryoLife, ... conference will allow institutional investors to meet with the ...
(Date:5/23/2012)... 2012 QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company U.S. Patent No. ... covers a method of treatment of pain comprising the ... compositions of MoxDuo IR (Immediate Release) for the ... (Controlled Release) for the treatment of chronic pain. ...
Breaking Medicine Technology:Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 2Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 3Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 4CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference 2QRxPharma Granted Additional US Patent on MoxDuo® 2QRxPharma Granted Additional US Patent on MoxDuo® 3Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 1Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 1Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 3Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 4Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 5Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 6Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 7Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 1Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 2Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 3Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 4
... NovaDel Pharma,Inc. (AMEX: NVD), a specialty pharmaceutical ... range of marketed treatments,today announced that its ... zolpidem tablets have met their primary,pharmacokinetic (PK), ... currently marketed as Ambien(R), a leading,drug for ...
... Oral Presentation Reports Significantly More Patients ... Least Three,Years, CHICAGO, June 04, 2007 ... (Taxotere plus,prednisone) maintained long-term efficacy as ... cancer patients,according to the three-year updated ...
Other Medicine Technology:NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: